We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
-2.43%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$958M
AUM Growth
-$53.5K
Cap. Flow
+$39.4M
Cap. Flow %
4.11%
Top 10 Hldgs %
7.33%
Holding
932
New
350
Increased
164
Reduced
151
Closed
267

Top Buys

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$9.48M
2
NKE icon
Nike
NKE
+$6.04M
3
GD icon
General Dynamics
GD
+$5.62M
4
SEDG icon
SolarEdge
SEDG
+$5.62M
5
DAY
Dayforce
DAY
+$5.58M

Top Sells

Rank Stock Value
1
PAYC icon
Paycom
PAYC
+$7.78M
2
CNM icon
Core & Main
CNM
+$7.41M
3
BG icon
Bunge Global
BG
+$6.82M
4
XEL icon
Xcel Energy
XEL
+$6.76M
5
SOFI icon
SoFi Technologies
SOFI
+$6.73M

Sector Composition

Rank Sector Weight
1 Technology 18.28%
2 Healthcare 14.75%
3 Consumer Discretionary 14.36%
4 Industrials 13.1%
5 Financials 12.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MUSA icon
226
Murphy USA
MUSA
$11.2B
$1.46M 0.15%
3,112
+573
+23% +$250K
STNE icon
227
StoneCo
STNE
$2.77B
$1.46M 0.15%
+121,579
New +$1.79M
TNET icon
228
TriNet
TNET
$3.02B
$1.46M 0.15%
14,587
+6,613
+83% +$736K
VIPS icon
229
Vipshop
VIPS
$7.37B
$1.45M 0.15%
+111,751
New +$1.78M
EPAM icon
230
EPAM Systems
EPAM
$5.51B
$1.45M 0.15%
7,729
-1,716
-18% -$366K
AROC icon
231
Archrock
AROC
$6.27B
$1.45M 0.15%
+71,875
New +$1.43M
NVS icon
232
Novartis
NVS
$297B
$1.45M 0.15%
13,647
+9,509
+230% +$955K
QDEL icon
233
QuidelOrtho
QDEL
$1.14B
$1.44M 0.15%
43,391
-6,424
-13% -$263K
QLYS icon
234
Qualys
QLYS
$5.1B
$1.44M 0.15%
10,108
+7,623
+307% +$1.16M
DDS icon
235
Dillards
DDS
$9.19B
$1.44M 0.15%
3,261
-2,193
-40% -$948K
MP icon
236
MP Materials
MP
$7.36B
$1.43M 0.15%
+112,360
New +$1.76M
TMO icon
237
Thermo Fisher Scientific
TMO
$213B
$1.43M 0.15%
2,586
+588
+29% +$337K
TRP icon
238
TC Energy
TRP
$70.2B
$1.42M 0.15%
+37,471
New +$1.42M
DB icon
239
Deutsche Bank
DB
$69B
$1.42M 0.15%
89,002
-48,722
-35% -$797K
GAP
240
The Gap Inc
GAP
$7.23B
$1.41M 0.15%
+59,045
New +$1.37M
SKYW icon
241
Skywest
SKYW
$4.24B
$1.41M 0.15%
+17,178
New +$1.28M
GLNG icon
242
Golar LNG
GLNG
$5B
$1.41M 0.15%
44,918
+8,502
+23% +$225K
SYY icon
243
Sysco
SYY
$40.8B
$1.4M 0.15%
+19,640
New +$1.47M
MRUS
244
DELISTED
Merus
MRUS
$1.4M 0.15%
+23,635
New +$1.14M
TEVA icon
245
Teva Pharmaceuticals
TEVA
$40.8B
$1.38M 0.14%
+85,154
New +$1.31M
FISV
246
Fiserv Inc
FISV
$28.8B
$1.37M 0.14%
+9,183
New +$1.39M
W icon
247
Wayfair
W
$11.2B
$1.35M 0.14%
+25,594
New +$1.52M
GPCR icon
248
Structure Therapeutics
GPCR
$3.41B
$1.35M 0.14%
+34,337
New +$1.41M
BHVN icon
249
Biohaven
BHVN
$2.03B
$1.34M 0.14%
+38,724
New +$1.53M
BMA icon
250
Banco Macro
BMA
$5.88B
$1.34M 0.14%
+23,443
New +$1.34M

Similar funds

Seven Eight Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Seven Eight Capital held 932 positions worth $958M, down 0.01% from $958M the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.

Seven Eight Capital deployed $39.4M of net new capital in Q2 2024, opening 350 new positions and adding to 164 existing holdings. Its largest new stake was General Dynamics: 19,203 shares worth $5.57M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Paycom, an estimated $7.78M trimmed.

  • Seven Eight Capital's largest Q2 2024 buy was General Dynamics: 19,203 shares worth $5.57M.
  • Seven Eight Capital added most to Stellantis in Q2 2024, an estimated $9.48M increase.
  • Seven Eight Capital's biggest Q2 2024 reduction was Paycom, cutting an estimated $7.78M.
  • Seven Eight Capital fully exited Core & Main in Q2 2024, selling an estimated $7.41M.
  • Seven Eight Capital's ten largest holdings make up 7.3% of its $958M portfolio in Q2 2024.
  • Seven Eight Capital opened 350 new positions and closed 267 in Q2 2024.
  • Seven Eight Capital's portfolio value fell 0.01% quarter-over-quarter to $958M.

Based on Seven Eight Capital's 13F filing for Q2 2024, filed 12 Aug 2024.